Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms.
about
Hepatic arterial embolization in patients with neuroendocrine tumorsGuidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumoursNew therapeutic approaches to metastatic gastroenteropancreatic neuroendocrine tumors: A glimpse into the future.Liver metastases of neuroendocrine tumours; early reduction of tumour load to improve life expectancyMalignant insulinoma: spectrum of unusual clinical features.Embolisation of cancer: what is the evidence?Transarterial chemoembolization and selective internal radiation for the treatment of patients with metastatic neuroendocrine tumors: a comparison of efficacy and cost.Radioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases.Hepatic neuroendocrine metastases: chemo- or bland embolization?Thailandepsin A-loaded and octreotide-functionalized unimolecular micelles for targeted neuroendocrine cancer therapy.Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.Emerging therapies for the treatment of patients with advanced neuroendocrine tumors.Selective Arterial Embolization of Liver Metastases from Gastrinomas: A Single-Centre Experience.Intra-arterial liver-directed therapies for neuroendocrine hepatic metastases.Embolization of metastatic neuroendocrine tumor resulting in clinical manifestations of syndrome of inappropriate secretion of antidiuretic hormone.Hepatic arterial chemoembolization using drug-eluting beads in gastrointestinal neuroendocrine tumor metastatic to the liver.Liver-directed therapies in liver metastases from neuroendocrine tumors of the gastrointestinal tract.Current status of embolic agents for liver tumor embolization.Surgical management of non-colorectal hepatic metastasis.Hepatic arterial embolization complicated by acute cholecystitis.Multimodal liver-directed management of neuroendocrine hepatic metastasesRadioembolization of symptomatic, unresectable neuroendocrine hepatic metastases using yttrium-90 microspheres.Hepatic arterial embolization for the treatment of metastatic neuroendocrine tumors.Hepatic artery embolization in advanced neuroendocrine tumors: Efficacy and long-term outcomes.Antineoplastic effects of histone deacetylase inhibitors in neuroendocrine cancer cells are mediated through transcriptional regulation of Notch1 by activator protein 1.Neuroendocrine Tumor-Targeted Upconversion Nanoparticle-Based Micelles for Simultaneous NIR-Controlled Combination Chemotherapy and Photodynamic Therapy, and Fluorescence Imaging.An overview of the surgical management of hepatic neuroendocrine metastases.Endovascular therapy for palliative care of cancer patients.Liver transarterial embolizations in metastatic neuroendocrine tumors.Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) in 2017.Predisposing factors of liver necrosis after transcatheter arterial chemoembolization in liver metastases from neuroendocrine tumor
P2860
Q21198838-429A424C-EC58-46C2-8C97-D72B0DB2124BQ24685837-4EDC1500-D1C5-438D-9AED-B0FCB2726ABCQ30364864-C7D863A9-63F3-49CE-9E8B-DECF6DF605A1Q33247993-8A475049-7374-4872-ADFC-789A050725F1Q34061054-78612B35-4F08-4835-AB2C-70B9D2020416Q34533357-2E9FC0AB-0F30-46F8-BE4B-34050531B3F6Q35584891-BD9E8BE5-9FB4-4465-894E-430C69FF5F02Q35721324-A929AF42-1F7D-4634-9783-FBF6231B58B8Q35930191-9A84E76C-A567-4171-9ABB-0B9A560C6C31Q35963760-6E0B278E-850D-49CD-93F7-0ADE6E9C75E5Q36205891-8AA4EEE4-A49A-4AAC-92AC-673BAAF063A7Q36866607-C77F1B63-EFB0-4A02-A60E-AAA8E15D16D2Q36961922-42A5E34D-6B45-432B-A8CD-A8FA83C6D07AQ36980633-7DAB7002-BE72-4B4E-A43E-A30A6A6F5D7CQ37343734-5B27B469-48A8-4993-8D93-322D4EFEFA90Q37856906-12880E2F-942F-425F-B2B2-09F95700FC83Q38019461-D10DACCE-69B8-4CEE-B123-40849C2CC10BQ38027067-528CC1E8-0027-4583-8872-1923DE507B20Q38152298-5012F6D1-E45E-4FDA-A50C-2BC6AD023F03Q38704615-C44774D5-1B1F-46DD-AB1D-F99C5A92C0C5Q38897797-87540D54-467D-4045-816C-1861BD24DC77Q40315003-83A7F796-CC30-4271-BE38-064706FFBDCDQ40869761-CFEDF414-CEB3-453C-BBB7-3E152779C960Q41053501-8A7D590B-6307-4DE0-862F-E0CD60B893E6Q41712392-E93391B1-60F8-4517-A248-7D6200369F15Q42011249-F71C5E54-37B9-46D0-AE70-852B345DD714Q42032092-9D809D37-D4E8-4BEA-8C99-176BFD3AD82EQ42594316-5D2F036F-BA1D-42D9-A7CA-C20BCEC214FFQ47869784-F732F373-C9A7-4F9F-A57C-1E661CBBE648Q55129582-B04A6A31-D024-48AF-9B16-3CA8C76A5D1FQ57145632-B0EC383E-37B5-42F4-9B07-F720E8211523
P2860
Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms.
description
1999 nî lūn-bûn
@nan
1999 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Particle embolization of hepat ...... of pain and hormonal symptoms.
@ast
Particle embolization of hepat ...... of pain and hormonal symptoms.
@en
type
label
Particle embolization of hepat ...... of pain and hormonal symptoms.
@ast
Particle embolization of hepat ...... of pain and hormonal symptoms.
@en
prefLabel
Particle embolization of hepat ...... of pain and hormonal symptoms.
@ast
Particle embolization of hepat ...... of pain and hormonal symptoms.
@en
P2093
P1476
Particle embolization of hepat ...... of pain and hormonal symptoms.
@en
P2093
Blumgart LH
Getrajdman GI
P304
P356
10.1016/S1051-0443(99)70055-2
P577
1999-04-01T00:00:00Z